S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Gemphire Therapeutics SEC Filings & 10K Form (NASDAQ:GEMP)

$0.37
-0.01 (-2.63 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$0.37
Now: $0.37
$0.40
50-Day Range
$0.33
MA: $0.42
$0.54
52-Week Range
$0.28
Now: $0.37
$1.60
Volume61,000 shs
Average Volume129,718 shs
Market Capitalization$5.50 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86

SEC Filings

Gemphire Therapeutics (NASDAQ:GEMP) SEC Filings

DateFilerForm TypeView
10/10/2019
8:35 PM
Gemphire Therapeutics (Filer)
Form S-4/A
10/08/2019
3:04 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
3:03 PM
Gemphire Therapeutics (Subject)
Form 425
10/03/2019
3:04 PM
Gemphire Therapeutics (Subject)
Form 425
09/24/2019
3:17 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
3:15 PM
Gemphire Therapeutics (Subject)
Form 425
08/15/2019
7:02 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
7:00 AM
Gemphire Therapeutics (Subject)
Form 425
08/13/2019
4:27 PM
Gemphire Therapeutics (Filer)
Form 8-K/A
08/13/2019
4:25 PM
Gemphire Therapeutics (Subject)
Form 425
08/09/2019
7:28 AM
Gemphire Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
7:16 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
7:14 AM
Gemphire Therapeutics (Subject)
Form 425
08/05/2019
7:21 AM
Gemphire Therapeutics (Subject)
NEUROBO PHARMACEUTICALS, INC. (Filed by)
Form SC 13D
08/02/2019
4:23 PM
Bisgaier Charles PhD (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13D
07/26/2019
3:38 PM
Gemphire Therapeutics (Issuer)
SASSINE ANDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:30 PM
Gemphire Therapeutics (Issuer)
LICHTINGER PEDRO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:24 PM
Gemphire Therapeutics (Issuer)
KOUSKY KENNETH W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:16 PM
Gemphire Therapeutics (Issuer)
Reno Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:10 PM
Bisgaier Charles PhD (Reporting)
Gemphire Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:01 PM
Gemphire Therapeutics (Issuer)
Gullans Steven R. Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
5:38 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
5:36 AM
Gemphire Therapeutics (Subject)
Form 425
07/24/2019
3:16 PM
Gemphire Therapeutics (Subject)
Form 425
07/16/2019
3:02 PM
Gemphire Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/26/2019
7:09 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
3:01 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:02 PM
Gemphire Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/22/2019
8:00 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
7:05 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
3:06 PM
Cormorant Asset Management, LP (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13G/A
02/14/2019
3:01 PM
Bisgaier Charles PhD (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13G/A
02/13/2019
4:14 PM
Gemphire Therapeutics (Subject)
PFIZER INC (Filed by)
Form SC 13G/A
02/06/2019
8:41 AM
Excel Venture Fund II, L.P. (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13G/A
01/31/2019
3:15 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
7:07 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
7:08 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
3:19 PM
Gemphire Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:07 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2018
3:49 PM
Gemphire Therapeutics (Filer)
Form 10-K/A
08/20/2018
3:10 PM
Gemphire Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
Form SC 13G
08/14/2018
11:37 AM
Gemphire Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2018
4:01 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
10:36 AM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:01 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:01 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2018
3:30 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2018
3:31 PM
Gemphire Therapeutics (Issuer)
Gullans Steven R. Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
3:11 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
3:04 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2018
3:40 PM
Gemphire Therapeutics (Filer)
Form DEFA14A
05/03/2018
3:18 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2018
5:01 AM
Gemphire Therapeutics (Filer)
Form DEF 14A
04/12/2018
3:02 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2018
4:28 PM
Gemphire Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/15/2018
3:03 PM
Gemphire Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
3:20 PM
Cormorant Asset Management, LLC (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13G/A
02/13/2018
11:59 AM
Excel Venture Fund II, L.P. (Filed by)
Gemphire Therapeutics (Subject)
Form SC 13G/A
02/09/2018
4:23 PM
Gemphire Therapeutics (Filer)
Form 424B5
01/30/2018
4:12 PM
Gemphire Therapeutics (Issuer)
SASSINE ANDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
4:04 PM
Gemphire Therapeutics (Issuer)
LICHTINGER PEDRO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:52 PM
Gemphire Therapeutics (Issuer)
KOUSKY KENNETH W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:44 PM
Gemphire Therapeutics (Issuer)
Hawryluk P. Kent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:36 PM
Bisgaier Charles PhD (Reporting)
Gemphire Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:27 PM
Gemphire Therapeutics (Issuer)
Golden Lee Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:20 PM
Gemphire Therapeutics (Issuer)
MATHIESEN JEFFREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:13 PM
Gemphire Therapeutics (Issuer)
Reno Seth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2018
3:06 PM
Gemphire Therapeutics (Issuer)
Gullans Steven R. Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2018
4:02 PM
Gemphire Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel